Saliva may hold key to concussion diagnosis and management

Quadrant Biosciences logo, invest, epigenetics, autism

Quadrant Biosciences

Simple saliva test also may predict nature and duration of concussion symptoms

SYRACUSE, NY, UNITED STATES, October 20, 2020 / — A simple saliva swab may hold the key to diagnosing and managing mild traumatic brain injury (i.e., concussions), according to a study recently published in the journal Clinical and Translational Medicine. In a paper titled "Diagnosing mild traumatic brain injury using saliva RNA compared to cognitive and balance testing,” researchers discovered that a noninvasive saliva test demonstrated similar diagnostic accuracy to neurocognitive and balance tests commonly used today, and greater diagnostic utility when combined with standardized symptom assessment. Moreover, the researchers from Penn State College of Medicine, SUNY Buffalo Jacobs School of Medicine, SUNY Upstate Medical and Quadrant Biosciences Inc., suggest that the saliva test may have additional clinical utility in predicting the type and duration of symptoms.

More than 3 million concussions occur each year, the majority occurring among children and young adults. Despite the prevalence of the injury, there are few clinically valid methods for its diagnosis or prognosis. As a result, there is great value in an objective biomarker that is not only accurate, but easily collected and measured.

“Currently, the diagnosis of concussion relies largely on subjective symptom reports from patients,” explains Steven Hicks, MD, Ph.D., FAAP, Associate Professor of Pediatrics, Penn State Hershey Medical Center and one of the co-authors in this study. “The lack of objective tools for concussion assessment is problematic because symptom reports can be manipulated to expedite, or delay, return to activities. As a result, studies have shown that concussion is often under-diagnosed.”

Quadrant Biosciences has been working the past several years with researchers from Penn State Medical Center and SUNY Upstate Medical University to explore the use of saliva biomarkers to objectively diagnose concussion. This earlier research, published in the Journal of the American Medical Association Pediatrics in 2018, identified a panel of small, non-coding molecules (“ncRNA”) in the saliva that acted as a "molecular signature" to not only diagnose concussion, but predict the duration and character of concussion symptoms. The present study was designed, in part, to test that diagnostic and prognostic utility in a larger cohort of patients.
In this study of 538 individuals across 11 test sites, the researchers compared the ability of saliva RNA to identify mTBI, relative to a commonly used symptom scale, balance test, and neurocognitive assessment. Saliva was collected using the ORAcollect®·RNA (OR-100) device from OraSure Technologies. The saliva test identified participants who had suffered mTBI with similar accuracy to standard clinical tools. The best performing predictive model included symptom reports combined with saliva RNA measures.

These results suggest that saliva RNA represents a non-invasive, biologic measure with the potential to aid concussion diagnosis. Hicks said predicting the length of concussions as early as possible would help ensure patients get the right care, and advise patients and parents on how long to expect symptoms to continue. “With that knowledge,” Hicks explained, “physicians could make more informed decisions about how long to hold a child out of sports, whether starting more aggressive medication regimens might be warranted, or whether involving a concussion specialist might be appropriate. Anytime we can use accurate, objective measures to guide medical care, I think that represents an opportunity to improve concussion treatment.”

While more studies are needed, Hicks said he is hopeful that measuring microRNAs in saliva could one day be an accurate, quick way to diagnose and manage concussions.

“The ultimate goal is to be able to objectively identify that a concussion has happened and then predict how long the symptoms will go on for,” Hicks said. “Then we can use that knowledge to improve the care that we provide for children who have concussions, either by starting medicine earlier or holding them out of activities for longer.”

Dr. Hicks serves as a paid consultant and scientific advisory board member for Quadrant Biosciences. These potential conflicts of interest have been fully disclosed and are actively managed by the Penn State Conflict of Interest Committee.

About Quadrant Biosciences
Quadrant Biosciences is a life science company involved in the development of functional assessments and epigenetic diagnostic solutions for large-scale health issues. The company has entered into collaborative research relationships with a number of institutions including SUNY Upstate Medical University and Penn State University to explore and develop novel biomarker technologies with a focus on Autism Spectrum Disorder, concussion, COVID-19, and Parkinson's Disease. Quadrant Biosciences also participates in the Start-up NY program, a New York State economic development program.

David MacLean
Quadrant Biosciences Inc
+1 3156142325
email us here
Visit us on social media:

Source: EIN Presswire

Incredible Growth Amidst a Global Pandemic

Microbe Formulas: Meridian, Idaho

Health Company Reports 2794.60% Revenue Growth in Its First 3 Years

MERIDIAN, IDAHO, UNITED STATES, October 20, 2020 / — Microbe Formulas, a health company, celebrates its first three years in business as of September. The company began with two doctors who wanted to provide effective, natural solutions for detoxification and gut health. Microbe Formulas has reported an astounding 2794.60% revenue growth from 2017 to present time.

When asked about the company's growth, CEO Ryan Riley explains: "Our company has seen incredible growth in our first three years in business. Despite the current challenges with the global economy, people are investing in their health now more than ever. We keep climbing to exceed our estimations in 2021. Our goal is to 10x our growth each year. To 10x our efforts individually and our output as a team."


Year-Over-Year Revenue Growth:

-Reported six figure gross earnings in 2017 after being in business for only six months out of the calendar year.

-Reported seven-figure earnings in 2018, which was the company’s first full calendar year in business. From 2017 to 2018, their annual revenue growth was 883.20%.

-In 2019, Microbe Formulas reported their first eight-figure year, with an annual revenue growth of 231.59%. They are currently sitting at 136.63% revenue growth in 2020, with 2.5 months remaining in the last quarter.

Product Growth:

-Their year-over-year product growth percentage is as follows: 2017–2018: 220%. 2018–2019: 118.18%. 2019–2020: 153.85%. The total number of supplement bottles sold from 2017 to date is 698,474.

-Microbe Formulas’ flagship product, Mimosa Pudica Seed, has helped thousands of people support their gut health and immunity by targeting pathogens in the digestive tract. Mimosa Pudica Seed has 732 product reviews on the Microbe Formulas website with a 4.6 star average, as well as 296 reviews on Amazon with a 4.3 star average.

-Since starting off with the product Mimosa Pudica Seed, they have created 19 other products that can be taken individually or as part of a complete detoxification protocol. They also have additional products only available through participating practitioners.

-Microbe Formulas’ unique selling proposition is their proprietary ingredient, BioActive Carbon Technology. Formulated by their team of leading scientists, BioActive Carbon is a new category of binders that effectively remove toxins to support whole body detoxification. BioActive Carbon doubles as a unique nutrient delivery method to drive and keep the integrity of each product’s ingredients.

Dave Huffman, VP of Marketing, adds: “It hasn’t been easy, but it is pretty simple. This is exactly what happens when you commit to creating solutions that actually work, then hire great people… listen to them, and make sure they have the clarity, tools, and space to do their best work.”

About Microbe Formulas: Microbe Formulas is a wellness company that emphasizes a healthy gut microbiome and true detoxification. Their core values are front and center in their company mission statement: “Creating solutions that work is what we do. Restoring hope and health is who we are.”

If you would like more information about this topic, please call Shawnda Huffman, Director of Public Relations for Microbe Formulas, at 208-274-8054 or email

Shawnda Huffman
Microbe Formulas
email us here

Source: EIN Presswire

Dr. Michael Dadson Awarded Canadian Certified Counsellor (CCC) Designation

Logo for Gentle Currents Therapy - Counselling and Neurofeedback Therapy Clinic in Langley, British Columbia

Gentle Currents Therapy – Counselling and Neurofeedback Therapy Clinic in Langley, British Columbia

Dr. Michael Dadson,  Ph.D. Counselling Psychology at Brookswood Langley

Dr. Michael Dadson, Ph.D. Counselling Psychology at Brookswood Langley

Dadson to Join Canadian Counselling and Psychotherapy Association (CCPA) Online Directory of Counsellors

I am very pleased and honoured to have received the Canadian Certified Counsellor designation recently and look forward to joining a wider network of mental health care professionals.”

— Dr. Michael Dadson

LANGLEY, BC, CANADA, October 20, 2020 / — Dr. Michael Dadson is a registered clinical counsellor and Senior Clinical Director of Practice at Gentle Currents Therapy and Neurofeedback, in Langley, British Columbia. Dr. Dadson primarily counsels clients with anxiety, depression, and post-traumatic stress disorder (PTSD), with a focus on couples counselling, first responders, and male mental health.

Canadian Certified Counsellor (CCC) Designation

Dr. Michael Dadson, a Registered Clinical Counsellor with decades of experience in the mental health field and an extensive list of certifications from various educational and regulatory bodies, has recently been awarded the Canadian Certified Counsellor (CCC) Designation by the Canadian Counselling and Psychotherapy Association (CCPA).

The CCPA is a national association of professionally trained counsellors engaged in the helping professions; the organization develops and cultivates both formal and informal relationships with similar health organizations in Canada and internationally.

According to the CCPA website:

“Obtaining the status of Canadian Certified Counsellor (CCC) includes recognition of standards of professional preparation, continuing education, and a formal code of ethics. As a non-statutory self-regulating body, CCPA provides advice and discipline for members on matters of professional conduct.”

Dr. Michael Dadson states:

“I am very pleased and honoured to have received the Canadian Certified Counsellor designation recently and look forward to joining a wider network of mental health care professionals.”

Dr. Michael Dadson’s certifications include:

• Canadian Certified Counsellor (CCC)
• Crime Victims Assistance Counsellor
• Certified QPRT Suicide Risk Assessment and Management
• Certified Observed and Experiential Integration (OEI) Therapist and Trainer
• Sensorimotor Psychotherapy Level One and Level Two
• Enactment Therapy Level One and Level Two
• Accelerated Experiential Dynamic Psychotherapy Level One
• Certified Myers-Briggs Personality Type Assessor
• Certified Strong Interest Inventory Assessor


Dr. Michael Dadson, Ph.D.
Langley, B.C.

Title: Senior Clinical Director of Practice, Gentle Currents Therapy – Counselling and Neurofeedback Therapy
YouTube Channel:


Specializing in trauma, anxiety, and depression, Michael Dadson, Ph.D., is a registered clinical counsellor and Senior Clinical Director of Practice at Gentle Currents Therapy, a Langley, B.C.-based counselling clinic. With expertise in trauma, stress, anxiety, and discrimination, Dadson’s clinical counselling can talk about the mental health impacts of anxiety about coronavirus and social isolation, how to handle anxiety about the coronavirus, and how to address issues related to helping children deal with traumatic events.

Michael Dadson has provided clinical treatment to individuals with a range of diagnoses, specializing in trauma and PTSD, anxiety and depression, male psychology, and relationship counselling for adults, adolescents, and children.

Michael Dadson and his wife, Jeanette Dadson, have also been assisting children with special needs and their families for over 30 years. As a Level III (3) therapeutic foster parent, Michael Dadson has worked with special needs foster children, and has been contracted through Intensive Child Care Resources Vancouver (ICCR). As a therapeutic foster parent, Dadson has lived and worked with Caucasian, Afghanistani, and First Nations children who have ADHD, Asperger’s Syndrome, FASD, major brain injuries and strokes.

Contact Registered Clinical Counsellor Michael Dadson today for information, advice, and insights on COVID-19 mental health implications, risks, community response, and talking to children.


CCC Designation:

Dr. Michael Dadson
Gentle Currents Therapy Counselling and Neurofeedback
+1 778-554-0174
email us here
Visit us on social media:

Source: EIN Presswire

Everyday Health Names Patrice Harris, MD, as its Medical Editor in Chief

Patrice A. Harris, MD, Everyday Health"s Medical Editor in Chief

Patrice A. Harris, MD

Everyday Health logo

Everyday Health Names Psychiatrist, Public Health Expert, and the First Black Female President of the AMA, Patrice Harris, MD, as its Medical Editor in Chief


Everyday Health is a trusted source of health information for millions; I am excited about the work we’ll create together to ensure mental health is front and center for each and every patient.”

— Dr. Patrice Harris

NEW YORK, NY, USA, October 20, 2020 / — The Everyday Health Group, a division of J2 Global Inc. (NASDAQ: JCOM), announces the appointment of Patrice Harris, MD, as Medical Editor in Chief for, its flagship consumer health and wellness resource. Dr. Harris, a physician who is regularly called on to advise on the current state of mental health and healthcare in America, will be featured in the next two episodes of Everyday Health’s Boxed In: COVID-19 and Your Mental Health video series (nine episodes have already aired in 2020 and are available to view free of charge). Dr. Harris will also help to oversee Everyday Health’s Black Health Facts: A Knowledge Movement.

Dr. Harris comes to Everyday Health with more than two decades of experience as a national health policy advocate, lecturer, educator, and practicing clinician. In June, Dr. Harris completed her one-year term as president of the American Medical Association, making history as the first Black woman to hold this role. Board-certified in psychiatry through the American Board of Psychiatry and Neurology, Dr. Harris focuses in her private practice on trauma and on child, adolescent, and adult psychiatry. Earlier this year, Dr. Harris was named one of the 50 Most Influential Clinical Executives by Modern Healthcare. She is also considered a national leader on the opioid overdose epidemic and chaired the AMA Opioid Task Force at its inception in 2014.

“We are thrilled to welcome Dr. Harris to Everyday Health,” says Dan Stone, President of the Everyday Health Group. “The combination of Dr. Harris’s deep expertise with Everyday Health’s trusted editorial platform will help educate patients to achieve better health and wellness outcomes.”

“Everyday Health is a trusted source of health information for millions of Americans, and I am excited about the work we’ll create together to ensure mental health is front and center for each and every patient, no matter where an individual is on their health journey, or their socioeconomic status, ethnicity, gender identity, or sexual identity,” says Dr. Harris. “A person’s ability to achieve their best state of overall health and mental wellness must include regular access to the latest resources, therapies, information, and ongoing support.”

“Patrice brings a wealth of experience in defining the issues that impact Americans’ mental health and emotional wellness at a time when the challenges facing the ever-growing number of Americans diagnosed with depression and anxiety is unprecedented,” says Maureen Connolly, Group Vice President and Editor in Chief of Everyday Health. “Over the past several years, we’ve made a bold commitment to teaching our audience the skills needed to achieve greater resilience when faced with traumatic experiences. We look forward to further expanding on our resources and services with Dr. Harris,” states Connolly.

Dr. Harris is a past member of the American Psychiatric Association’s Board of Trustees and a past president of the Georgia Psychiatric Physicians Association. She was an American Academy of Pain Medicine Presidential Commendation honoree and is a coauthor of the National Academy of Medicine’s First Do No Harm: Marshaling Clinician Leadership to Counter the Opioid Epidemic. She continues to work in private practice in Atlanta and is an adjunct professor in the department of psychiatry and behavioral sciences at the Emory University School of Medicine, as well as an adjunct clinical professor in the department of psychiatry and behavioral sciences at the Morehouse School of Medicine. Dr. Harris is board-certified in psychiatry and holds a doctor of medicine degree from the West Virginia University School of Medicine in Morgantown.

“We are deeply honored that Dr. Patrice Harris has joined our mission at Everyday Health to inspire and enable wellness. Dr. Harris will bring even more clinical expertise and evidence-based medical science in mental health along with her passion, compassion, and conviction that there is much more that we can do to help those in need,” states Nan-Kirsten Forte, Executive Vice President and General Manager of Everyday Health Consumer.

About the Everyday Health Group
The Everyday Health Group (EHG) is a recognized leader in patient and provider education attracting an engaged audience of over 56 million U.S. health consumers and over 830,000 U.S. practicing physicians and clinicians to its premier health and wellness digital properties. EHG combines social listening data and analytics expertise to deliver highly personalized healthcare consumer content and effective patient engagement solutions. EHG's vision is to drive better clinical and health outcomes through decision-making informed by highly relevant data and analytics. Healthcare professionals and consumers are empowered with trusted content and services through the Everyday Health Group's flagship brands including Everyday Health®, What to Expect®, BabyCenter®, MedPage Today®, Health eCareers®, PRIME® Education, Castle Connolly Top Doctors®, and our exclusive partnership with Mayo Clinic® and The Mayo Clinic® Diet. The Everyday Health Group is a division of J2 Global Inc. (NASDAQ: JCOM) and is headquartered in New York City. For more information, go to

To arrange an interview, please contact Janice Dehn:

Janice Dehn
Everyday Health Group

Source: EIN Presswire

Educated Singles are seeking new exclusive online communities after COVID-19

The Educated Singles Club

Educated Singles Club

3 purposes of The Educated Singles Club - Dating, Socialising and Networking

3 purposes of The Educated Singles Club – Dating, Socialising and Networking

My owner needs a day - help her

My owner needs a day – help her

Educated singles opt-out traditional dating sites when looking for social life online. Many fake profiles and too much focus on appearance are the reasons

It is a top priority that The Educated Singles Club has the highest level of authenticity so that all members can feel safe”

— Finn Majlergaard

NICE, FRANCE, October 20, 2020 / — COVID-19 has closed down social life as we knew it in many parts of the world. Educated Singles who traditionally work a lot want to spend their free time with likeminded individuals.

Swiping through thousands of photos in the search for the next date appeal to many people but not the well-educated singles. They are far more demanding.

The thrive for authenticity, quality and exclusiveness has led to a surge in members in The Educated Singles Club, which is very different from a tradition dating site. For many members of The Educated Singles Club finding a date is not the first priority. Instead, it can be finding other singles with common interests, views on life or similar profession or education. That unique approach opens the opportunity to become attracted to another person both intellectually and emotionally and not just physically but looking at a photo. Furthermore, the members have all the time they need to develop relations in their preferred way in a safe environment.

All members are carefully screened before they are accepted. You need to have at least a masters degree and a mature LinkedIn profile where credentials can be verified. 9 out of 10 membership applications are rejected because the requirements are not met.

Members have to pay a membership fee to cover the costs of running the club. Maintaining the highest level of authenticity and safety for the members is the top priority. That can only be achieved if the costs are covered by the members themselves.

Educated singles are well aware of all the risks of joining free dating sites. Nothing is course free, but the price you pay by joining a free dating site is both intransparent and often very high. You will often see a lot of fake profiles and some dating sites have robots sending messages to members pretending to be people interested in dating, etc. Of course, you can respond to these messages without upgrading to a paid profile.

From the very beginning, The Educated Singles club decided to be very different. No fake profiles, no hidden costs and making sure that all the members can feel certain that all other members are real genuine people who are who they appear to be.

That has been a successful approach, especially after the COVID-19 outbreak where it has been challenging for well-educated singles to find substitutes for their quality social life.

Dr Finn Majlergaard
The Educated Singles Club
+33 652973199
email us here
Visit us on social media:

Source: EIN Presswire

CCHR Urges Overhaul of Teen Behavioral Industry: 30 Years of Children at Risk

CCHR Urges Overhaul of Teen Behavioral Industry: 30 Years of Children at Risk

Mental Health Watchdog compares teen psychiatric abuses of the ‘90s with today’s, documenting decades of harm in for-profit behavioral system. The industry needs tough accountability for “behavior modification,” child restraints and other abuse, to protec

Mental Health Watchdog compares teen psychiatric abuses of the ‘90s with today’s, documenting decades of harm in for-profit behavioral system.

LOS ANGELES, CALIFORNIA, UNITED STATES, October 20, 2020 / — Citizens Commission on Human Rights International, a mental health industry watchdog, announced that following the November elections it will call on the Federal government to overhaul the “troubled teen” behavioral industry after 30 years of neglect. CCHR was pivotal in exposing the assault and abuse of thousands of teens in the psychiatric system in the 90s. While there were some reforms, oversight remained lax, it says. Drawing upon its research and media exposés at the time and comparing them to recent allegations of sexual and physical assaults and restraint of children in psychiatric and behavioral facilities, the group said the lack of oversight and accountability may have put hundreds of thousands of children’s lives at risk, including of suicide and death over the past three decades.

The group says the recent Paris Hilton documentary exposing her forced 11-month incarceration in a behavioral youth “school” in 1999, prompted CCHR to revisit the early 1990s, when the “frenzy” to shanghai kids into behavioral facilities was likened by one California official to Invasion of the Body Snatchers.[1] Hilton said she was beaten, placed in solitary confinement and forcibly drugged. Paris and other survivors are part of the #BreakingCodeSilence movement, which launched a petition that says there is “no real oversight to protect the children’s human rights and safety” in such facilities today.[2]

CCHR says it’s unconscionable that the behavioral-child psychiatric industry has continued to ignore what survivors, parents, groups and in 1991, The New York Times, championed: the need for better regulation, oversight and accountability[3]—the same call is being made three decades later. The Times reported that investigators looked into for-profit psychiatric hospitals, including Charter behavioral health.[4] Charter closed in the wake of federal investigations and multi-million-dollar fines in 2000. The company owned Provo Canyon behavioral “school” where Hilton was abused, before selling it to Universal Health Services (UHS), whose behavioral sector has been subject to allegations of patient abuse for 15 years.[5]

In 1994, Joe Sharkey, a former columnist for The New York Times wrote an exposé of the industry in Bedlam: Greed, Profiteering, and Fraud in a Mental Health System Gone Crazy. “Pure economics explains the psychiatric hospitals’ inordinate interest in children,” because, he said, the profit margin for a psychiatric bed occupied was 20% but for a child it was 30%.[6]

Sharkey noted, “In trolling for more affluent children and adolescents, psychiatric hospitals cleverly used advertising and the media to exploit parental concerns about drug and alcohol abuse, as well as eating disorders, poor school performance…family crises, and even normal adolescent sulkiness and alienation.”[7] Parental anxieties were “brilliantly exploited by aggressive marketing designed to sell psychiatric hospitalization as the answer to juvenile behavior problems and the key to household peace,” Sharkey wrote.[8] In one year, a major chain of psychiatric hospitals spent $14 million on advertising.[9]

Professor Ira Schwartz, a leading national authority on youth policy, called it the “biggest child welfare scandal of the last 50 years.”[10] Despite the exposure of this, in 2015, a thesis about the “Troubled Teen Industry” found that although there has been Congressional hearings, Governmental Accountability Office reports, and “prolifically documented individual testimonies and lawsuits related to abuse and wrongful death,” “this industry continues to flourish with massive profit margins.”[11]

Today, media report that teens are still often forcibly taken from their homes and shipped off to behavioral schools, sometimes not seeing their parents for two years. Places like Provo Canyon, The New York Post said, have “profited handsomely” from the teen behavioral system “not only by getting parents to fork over more than $7,000 per month, but also collecting money from Medicaid so foster children and other ‘unwanted’ kids can be dumped there.”[12]

UHS recently agreed to pay $132 million to settle federal and state investigations into its behavioral sector.[13] In its July Securities and Exchange Commission report, UHS denied the allegations raised or any liability. Instead, “[I]n exchange for the OIG’s [Office of Inspector General] agreement not to exclude the Company and its behavioral health subsidiaries from participating in the federal health care programs,” UHS entered into a five-year corporate integrity agreement with the OIG, which includes “monitoring.”[14]

However, CCHR said it saw the same deals made to maintain industry operations and profits in the 1990s. CCHR warned that that this left in place an abusive behavioral-psychiatric system that is lenient about children put at risk of suicide, staff sexual and physical assault, damaging behavior-modification treatment, and restraint deaths. While CCHR works towards Congressional reform, it urges parents to visit its website for information and laws to help safeguard children and adolescents.

CCHR is a mental health watchdog responsible for more than 180 laws that protect patients from damaging psychiatric practices. DONATE to support its work here:


[1] Joe Sharkey, Bedlam: Greed, Profiteering, and Fraud in a Mental Health System Gone Crazy (St. Martin’s Press, New York, 1994), p. 90.


[3] “Paying for Fraud/A special report.; Mental Hospital Chains Accused of Much Cheating on Insurance,” The New York Times, 24 Nov. 1991,

[4] Ibid.


[6] Op. cit., Joe Sharkey, p. 90.

[7] Ibid., p. 92

[8] Ibid., p. 98

[9] Ibid., p. 95

[10] Ibid., p. 12.


[12] Dana Kennedy, “Inside the ‘abusive’ troubled-teen industry that Paris Hilton exposed,” The New York Post, 30 Sept. 2020,

[13], citing: “Universal Health Services, Inc. to Pay $117 Million to Settle False Claims Act Allegations,” Dept. of Justice Eastern District of Pennsylvania, 10 July 2020,; “Universal Health Services to Pay Massachusetts More than $15 Million to Resolve Whistleblower False Claims Cases,”, 13 July 2020,


Amber Rauscher
Citizens Commission on Human Rights
+1 323-467-4242
email us here
Visit us on social media:

Source: EIN Presswire

World-first study proves it's time to “Rethink Pink”

New independent research debunks the myth that pink salt is healthier than white table salt

SYDNEY, NEW SOUTH WALES, AUSTRALIA, October 20, 2020 / — A world-first study led by independent research company, Nutrition Research Australia (NRAUS), has shown that pink salts embody low levels of essential nutrients and a wide variation of harmful heavy metals.

Results garnered from testing 31 samples of pink salts available for purchase in Australia revealed they are unpredictable and inconsistent in nature.

Wide variations in the levels of nutrients found in pink salt were significant, with iron levels ranging between 0 and 17mg/100g and in the case of calcium levels ranged between 53mg and 574mg/100g.

Pink salt samples with higher concentrations of essential nutrients also comprised higher levels of heavy metals.

More alarmingly, some pink salt samples contained aluminium (up to 19mg/100g) and lead (up to 0.26mg/100g, with one sample exceeding national contaminant levels) – both heavy metals that are harmful if consumed long-term or in excess.

Interestingly, all of the Australian-sourced pink salt samples showed lower levels in both essential nutrients and non-nutritive minerals, including heavy metals.

While the research shows pink salt contains more nutrients than white table salt, consumption needs to exceed the recommended sodium limit by over 500% before gaining any meaningful contribution to the diet.

The top three nutrients found in pink salt (excluding sodium) were magnesium, calcium and potassium, but one teaspoon only contributed between 1% and 5% of daily needs, and 100% of the maximum sodium limits (5g of salt).

The top three non-nutritive minerals in pink salt were sulphur (100% of samples / at least five times more than white); aluminium (93% of samples / not present in white); and silicon (83% of samples / not present in white).

Results have NRAUS calling on Australians to “Rethink Pink”, as while pink salt contains more minerals than white table salt, the amounts are not meaningful and limiting salt intake from all sources will help Australians to align with recommendations from the World Health Organization.

NRAUS funded the research independently after CEO, Dr Flavia Fayet-Moore identified zero proof was available on pink salt’s nutrient composition and the research group felt Australians need more evidence to make an informed choice.

“Our study shows that pink salt’s reputation for being ‘healthier’ has now been debunked, with the nutrient level too low and variable for it to be a consistent source of nutrients. People would need to consume six teaspoons of pink salt for those nutrients to make a meaningful contribution to their diet, which far exceeds dietary guidelines and is detrimental to health.

“While pink salt may look prettier on the dining room table, there are many healthy ways to enhance flavour and add colour to your meal, such as using herbs and spices like paprika, turmeric, cinnamon, saffron and even pink peppercorns.”

Nutrition scientist and dietitian, Dr Joanna McMillan co-authored the manuscript with NRAUS scientists and also encourages Australians to consider alternatives when looking for flavour.

“There are healthier substitutes for salt, that add flavour to your diet without the health risk. It is actually possible to retrain your tastebuds, so we challenge Australian households to try new things and have fun adding flavour to meals with natural flavor enhancers like umami foods, seaweed or by using fresh herbs and spices.”

Insights gained from the study indicated that the unpredictable nature of pink salts and its mineral composition could not even be attributed to factors like origin or intensity of the pink colour.

The 31 samples tested during NRAUS’ study were products readily available in Australian supermarkets and independent retailers, and sourced from around the world.

The full media release, infographic and research paper can be viewed

-Ends –

For further media enquiries, please contact Lauren Zammit on +61 491 629 919 /

We Do PR
+61 491 629 919
Visit us on social media:

Source: EIN Presswire

Aldevron Promotes Venkata Indurthi to Vice President of Research and Development

Headshot of Venkata Indurthi, Vice President of Research and Development at Aldevron

Venkata Indurthi, Vice President of Research and Development

Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteins, has promoted Venkata Indurthi to Vice President of Research and Development.

I am grateful to be part of a company that has redefined the boundaries of biologics manufacturing. I will build upon that legacy and create a team that will be a nucleus of innovation for Aldevron.”

— Venkata Indurthi

FARGO, NORTH DAKOTA, UNITED STATES, October 20, 2020 / — Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteins, has promoted Venkata Indurthi to Vice President of Research and Development (R&D). He will begin this new role immediately and continue reporting to John Ballantyne, Co-founder and Chief Scientific Officer while having direct access to Aldevron’s senior executive team.

Indurthi will lead Aldevron’s team of scientists as they undertake new ways to innovate and introduce products and services to clients. He will also serve as operational lead for all RNA-focused developments, arguably the most promising technique to solve major worth health challenges. Indurthi will provide essential leadership and structure while focusing on strategic opportunities to help further establish Aldevron as an R&D leader, to help grow sales and to foster long-term relationships in the U.S. and global markets.

“Venkata joined Aldevron in 2015, bringing a natural acumen for science and inherent ability to see possibility,” said John Ballantyne. “He led the charge for our RNA manufacturing process, bringing Aldevron to a leadership position in the industry. As Vice President of R&D, I am confident that our team will thrive under his leadership thanks to his client-centric approach, and his passion for developing new ways to solve problems. He is the absolute right person for this new role.”

After stints as a research intern at Veer Chemie & Aromatics Limited and the National Institute of Nutrition, both in Hyderabad, India, Indurthi became a graduate research assistant at North Dakota State University (NDSU), where he also earned his PhD in Pharmaceutical Sciences. He started his career with Aldevron as a QC Scientist, followed by a position as Senior Scientist in Product and Process Design, Director of R&D and most recently as Director of RNA Operations.

“I am grateful to be part of a company that has redefined the boundaries of biologics manufacturing,” said Indurthi. “In my new role, I will build upon that legacy and create a team that will be a nucleus of innovation for Aldevron.”

Aldevron’s values include serving clients and the industry through collaboration, focusing on the best outcome; a mindset that is pervasive with all staff. “Venkata has demonstrated his passion for the work and for Aldevron every day since he has started,” said Kevin Ballinger, CEO of Aldevron. “This promotion is well deserved, and I look forward to witnessing the new heights our R&D team will reach under his leadership.”

Indurthi graduated with B.S. degree in Biotechnology from SRM University, Chennai, India, and his PhD in Pharmaceutical Science from NDSU.

Aldevron serves the biotechnology industry with custom production of nucleic acids and proteins. Thousands of clients use Aldevron-produced plasmids, RNA and gene editing enzymes for projects ranging from research grade to clinical trials to commercial applications. The Company specializes in GMP manufacturing and is known for inventing the GMP-Source® quality system. Aldevron’s 14-acre campus headquarters is located in Fargo, N.D. and is the world’s largest DNA and RNA manufacturing facility. The company’s protein development and manufacturing operations are located in Madison, WI.

Ellen Shafer
+1 701-551-8704
email us here

Source: EIN Presswire

Helmholtz Zentrum Berlin and Park Systems Start a Research Collaboration in Materials Science

Park Systems’ and HZB’s Research Collaboration in Materials Science

Park Systems and Helmholtz Zentrum Berlin sign an agreement about a framework for joint research and development of metrology solutions for materials science

We are particularly happy that with Park Systems we found a strong partner from industry who is known for their support of scientific research.”

— Prof. Dr. Bernd Rech, Scientific Managing Director of HZB

MANNHEIM, GERMANY, October 20, 2020 / — Park Systems, a leading manufacturer of Atomic Force Microscopes (AFM) and the Helmholtz Zentrum Berlin (HZB), an internationally renowned and recognized research center in the field of materials for a sustainable energy supply, have signed an agreement providing a framework for joint research and development of metrology solutions for materials science.

The HZB disposes of a strong expertise in the energy research as well as in the field of quantum materials. Together with more than 20 years’ experience of Park Systems in developing nanotechnology solutions for metrology applications, the cooperation partners bundle their specialist knowledge in order to investigate, improve existing and to develop next generation measurement technologies for future applications in material sciences.

“We are extremely excited about the new collaboration with such a prominent research institution like Helmholtz Zentrum Berlin. It is Park Systems’ mission and research area to help develop nanotechnology instruments for pushing forwards globally relevant applications such as energy conversion and storage. I am sure that the collaboration with HZB will bring significant fruits in this field,” comments Dr. Sang-Joon Cho, Head of Advanced Application Technology Center at Park Systems Corp.

„In order to enable and transfer breakthroughs in materials research at Helmholtz Zentrum Berlin we are continuously looking to extend and strengthen partnerships with industry. We are particularly happy that with Park Systems we found a strong partner from industry who is known for their support of scientific research. This new cooperation in the field of nano science and technology is extraordinarily beneficial to both sides,” adds Prof. Dr. Bernd Rech, Scientific Managing Director of Helmholtz Zentrum Berlin für Materialien und Energie GmbH.

Park Systems is funding a doctoral thesis for the purposes of the collaboration project. The research is carried out at the HZB with Park Systems AFM instruments.

About Park Systems
Park Systems, a world-leading manufacturer of Atomic Force Microscopy (AFM), enables researchers and engineers around the globe to contribute to impactful science and technological development that helps humanity to grow and improve life standards.
Thanks to the high-level technological know-how and 100% commitment, the professionals at Park provide innovative application solutions for material and life science disciplines, to and with their customers.
With Park’s high-performance scientific instruments for research and industrial communities we help to explore new phenomena in chemistry, materials, physics, life sciences, semiconductor and data storage industries. Cutting-edge AFM automation and the highest data accuracy enables to become more efficient, more accurate and more productive at your work.
Visit for more information.

Justyna Sliwa
Park Systems Europe
+49 621 49089650
email us here

Source: EIN Presswire

Contraceptives Market Share Will Increase by 6.8% CAGR, Global Growing Healthcare Industry Crucial Key Players by 2025

Contraceptives Market

Contraceptives Market

Condom segment generated highest revenue, accounted for $6,053 mn in the world contraceptive devices market and projected to retain its dominance during period

PUNE, MAHARASHTRA, INDIA, October 20, 2020 / — Initiatives taken by regulatory bodies and government organizations to mandate the use of barrier contraceptives such as condoms have significant impact on the growth of contraceptive market. Contraceptive methods for home use are effective and convenient, owing to the cost-effectiveness of these products.

A new report published by Allied Market Research titled, Contraceptives Market by Product, Age Group, Education, and End User – Global Opportunity Analysis and Industry Forecasts, 2019 -2025, projects that the global market for contraceptives would reach $43,812 million by 2022 from $28,175 million in 2015, growing at a CAGR of 6.4% from 2016 to 2025. Contraceptive drugs are expected to dominate the market throughout the study period. North America would continue its lead, accounting for more than one-third share of the world contraceptive market in 2018.

Download Free Sample PDF of Report:

Condoms is expected to dominate the overall contraceptives device market throughout the analysis period, due to the increase in demand in developed as well as developing economies. Male condoms are more popular than female condoms; thereby significantly boosting the growth of the overall contraceptive market.

The increase in popularity of male condoms is attributed to their easy accessibility, ease-of-use, and wide acceptance across various regions. Furthermore, intrauterine (IUD) segment is anticipated to exhibit the highest growth, registering a CAGR of 10.1% during the forecast period, owing to their effectiveness in prevention of unwanted pregnancies for almost 1012 years after insertion in the body and transmission of STDs.

Based on age group, women ranging between 15 and 24 years, are the major contributors to generate highest revenue in the world contraceptive market. This is owing to the increased usage of contraceptives among the teenagers and early maturity among the teenage girls, raising the demand for contraceptives. However, women aged above 44, are the least contributor to the market growth due to the menopause in women at the age 44 and above.

The key players in the contraceptives market are highly focused to expand their business operations in the fast-growing emerging countries and launched new products to increase their market shares. The key players profiled in this report include The Female Health Company, Teva Pharmaceutical Industries Limited, Allergan plc, Bayer AG, Pfizer, Inc., Cooper Companies, INC., Ansell LTD., Mayer Laboratories, Merck & Co., Inc., and Church & Dwight, Co., Inc. Other players in the value chain include Reckitt Benckiser Plc, BioSante Pharmaceuticals Inc., Warner Chilcott Company, Agile Therapeutics Inc., MANKIND Pharmaceuticals, HLL Lifecare Limited, TTK HealthCare, Watson Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, V-Care Pharma Pvt. Ltd., Vardhman Life care pvt. Ltd., Cipla Limited and others.

For Purchase Enquiry at:

The North American region accounted for majority of the share of the world contraceptives market in 2015. The North American contraceptive market is expected to maintain its lead throughout the forecast period due to increase in awareness among the population, rise in adoption of modern contraceptives, and increase in prevalence of sexually transmitted diseases such as HIV/AIDS. The U.S. contraceptive market accounts for the largest share in the overall North America contraceptive market. Asia-Pacific region is expected to grow at the fastest pace during the study period, owing to high population base, and proactive governmental bodies that focus on birth control. Moreover, technological advancements and cost-effective contraceptive products in these regions offer lucrative opportunities to contraceptive manufacturers.

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

Shadab Pathan
Allied Market Research
+1 800-792-5285
email us here

Source: EIN Presswire